No link between leukemia risk and nuclear plants

	Tweet

Children living near nuclear plants in France do not have an increased risk of leukemia, a new study confirms.

Most studies that have examined cancer risk near nuclear installations have looked only at how far a child lives from the plant, Dr. Jacqueline Clavel of Universite Paris Sud, Villejuif and colleagues note, assuming that the greater the distance, the lower the radiation exposure. However, radiation dispersion follows a more complex pattern, they note.

To get a more accurate picture of the risk, Clavel and her team divided regions around each of 23 different French nuclear plants into five zones based on radiation exposure to the red bone marrow (RBM) due to gaseous discharge from the plant. They evaluated the rate of leukemia diagnoses among children younger than 15 years old between 1990 and 2001 over 40 square kilometers around each plant.

A total of 750 cases of leukemia were diagnosed, slightly lower than the 795 cases that would have been expected, although the difference was not statistically significant. The researchers also found no evidence of an increased risk that correlated with increased radiation exposure.

The average radiation exposure from gaseous discharge was very low, a small fraction of the estimated exposure from natural sources of ionizing radiation, such as radon, or from medical tests, such as X-ray imaging.

The average RBM dose from gaseous radioactive discharge among children who lived in the vicinity of nuclear plants was about 1,000 to 10,000 times lower than the average RBM dose from natural sources, Clavel and her colleagues report.

They conclude that there was no evidence of an increase in the rate of childhood leukemia in the vicinity of these 23 French nuclear plants between 1990 and 2001.

SOURCE: British Journal of Cancer, May 8, 2004.

RELATED STORIES:
Drug That Modifies Gene Activity Could Help Some Older Leukemia Patients   Researchers Seek Alternative for Leukemia Patients Resistant to Standard Therapies   Stress Hormone May Hasten the Progression of Certain Blood Cancers   Smarter use of existing treatment helps dramatically boost survival of young AML patients   Anemia ups hospitalization, death risk for elderly   Mutations Point the Way to New Leukemia Drugs   Exercise Benefits Leukemia Patients   Immunotherapy demonstrates long-term success in treating lymphoma   Burkitt lymphoma gene expression signature identified   Formaldehyde raises risk of deadly cancers: study   Hodgkin’s survivors at increased risk for leukemia   Celgene drug boosts multiple myeloma survival   Study reveals need for personalized approach in treatment of AML   Drug Fights Multiple Myeloma by Putting “Brakes” on Cell Proliferation   China scientists show how arsenic treats blood cancer   Researchers Unlock Mystery of Very Aggressive Leukemia   Individualizing Treatment for Multiple Myeloma Patients   Researchers discover genetic differences between lethal and treatable forms of leukemia   Petrochemicals linked to leukemia in young adults   2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma   Disparities among patients with extremity soft-tissue sarcomas   Adult height lower in childhood leukemia survivors

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]